Cargando…
1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454348/ http://dx.doi.org/10.1016/j.annonc.2021.08.1581 |
| _version_ | 1784570469367676928 |
|---|---|
| author | Patel, M. Felip, E. Sharkey, R. Krengli, M. Chester, J.D. Sita-Lumsden, A. Mukherjee, U. Russell, B. Loizidou, A. Colomba, J. Cruz, C. Andrea Cabirta, A. Camps, I. Ruiz Brunet, J. Sureda, A. Patriarca, A. Tondini, C. Pinato, D.J. Cortellini, A. |
| author_facet | Patel, M. Felip, E. Sharkey, R. Krengli, M. Chester, J.D. Sita-Lumsden, A. Mukherjee, U. Russell, B. Loizidou, A. Colomba, J. Cruz, C. Andrea Cabirta, A. Camps, I. Ruiz Brunet, J. Sureda, A. Patriarca, A. Tondini, C. Pinato, D.J. Cortellini, A. |
| author_sort | Patel, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8454348 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84543482021-09-21 1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19 Patel, M. Felip, E. Sharkey, R. Krengli, M. Chester, J.D. Sita-Lumsden, A. Mukherjee, U. Russell, B. Loizidou, A. Colomba, J. Cruz, C. Andrea Cabirta, A. Camps, I. Ruiz Brunet, J. Sureda, A. Patriarca, A. Tondini, C. Pinato, D.J. Cortellini, A. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454348/ http://dx.doi.org/10.1016/j.annonc.2021.08.1581 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Patel, M. Felip, E. Sharkey, R. Krengli, M. Chester, J.D. Sita-Lumsden, A. Mukherjee, U. Russell, B. Loizidou, A. Colomba, J. Cruz, C. Andrea Cabirta, A. Camps, I. Ruiz Brunet, J. Sureda, A. Patriarca, A. Tondini, C. Pinato, D.J. Cortellini, A. 1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19 |
| title | 1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19 |
| title_full | 1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19 |
| title_fullStr | 1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19 |
| title_full_unstemmed | 1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19 |
| title_short | 1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19 |
| title_sort | 1588p sars-cov-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454348/ http://dx.doi.org/10.1016/j.annonc.2021.08.1581 |
| work_keys_str_mv | AT patelm 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT felipe 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT sharkeyr 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT krenglim 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT chesterjd 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT sitalumsdena 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT mukherjeeu 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT russellb 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT loizidoua 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT colombaj 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT cruzcandrea 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT cabirtaa 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT campsiruiz 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT brunetj 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT suredaa 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT patriarcaa 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT tondinic 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT pinatodj 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 AT cortellinia 1588psarscov2antibodyseroprevalenceandsafetyofvaccinesincancerpatientswhorecoveredfromcovid19 |